Anti-inflammatory effects of low- and high-dose atorvastatin therapy in patients with coronary heart disease and rheumatoid arthritis
Aim. To assess the dynamics of an inflammatory marker, C-reactive protein (CRP), and lipid profile during 3-month high- and low-dose atorvastatin therapy (40 mg/d and 10 mg/d) in patients with rheumatoid arthritis (RA) or coronary heart disease (CHD) and moderate hyperlipidemia (HLP).Material and me...
Main Authors: | V. S. Tutunov, T. V. Popkova, D. S. Novikova, E. L. Nasonov, V. V. Kukharchuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1085 |
Similar Items
-
Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
by: Zhaleh Shariati Sarabi, et al.
Published: (2016-08-01) -
EFFECTS OF ATORVASTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND DYSLIPIDEMIA
by: N. M. Nikitina, et al.
Published: (2014-07-01) -
EFFECTS OF ATORVASTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND DYSLIPIDEMIA
by: N. M. Nikitina, et al.
Published: (2014-07-01) -
RISK FACTORS OF CORONARY ARTERY STENOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2018-01-01) -
Prophylaxis of cardiovascular diseases in rheumatoid arthritis
by: D S Novikova, et al.
Published: (2009-05-01)